Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Opioid Use Disorder · Opioid Dependence

Indivior Pty

Indivior Pty Ltd

Indivior Pty clinical programs — 39 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
Status
Public
HQ
., Richmond, VA, US
Employees
967
Programs
39
Drugs
19
Patents
34
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Indivior Pty projects

39 ClinicalTrials.gov programs sponsored by Indivior Pty.

Indivior Pty has 39 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

39 programs

Clinical programs

  1. Intranasal challenge drug

    Indivior Pty Ltd

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

  2. RBP-6000

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 3 small molecule completed

    4 trials

  3. RBP-7000

    Indivior Pty Ltd

    Schizophrenia

    phase 3 small molecule completed

    5 trials

  4. SUBLOCADE

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 3 small molecule terminated

    2 trials

  5. SUBOXONE

    Indivior Pty Ltd

    Opioid Dependence

    phase 3 small molecule completed

    1 trial

  6. SUBOXONE sublingual film

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 3 small molecule completed

    1 trial

  7. Arbaclofen Placarbil

    Indivior Pty Ltd

    Alcohol Use Disorder

    phase 2 small molecule completed

    1 trial

  8. Buprenorphine

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  9. Buprenorphine hydrochloride marketed sublingual tablet (Subutex)

    Indivior Pty Ltd

    Opioid Dependency

    phase 2 small molecule completed

    1 trial

  10. Buprenorphine soluble film

    Indivior Pty Ltd

    Opioid-related Disorders

    phase 2 small molecule completed

    1 trial

  11. Buprenorphine/naloxone Film Strip

    Indivior Pty Ltd

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  12. INDV-2000

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  13. INDV-6001

    Indivior Pty Ltd

    Moderate to Severe Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  14. RBP-6000

    Indivior Pty Ltd

    Opioid Related Disorder

    phase 2 small molecule completed

    1 trial

  15. RBP-6300

    Indivior Pty Ltd

    Opioid Related Disorder

    phase 2 small molecule completed

    1 trial

  16. RBP-8000 100 mg

    Indivior Pty Ltd

    Opioid Dependence

    phase 2 small molecule completed

    1 trial

  17. Risperidone

    Indivior Pty Ltd

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  18. XP19986 CR

    Indivior Pty Ltd

    GERD

    phase 2 small molecule completed

    1 trial

  19. Arbaclofen Placarbil SR

    Indivior Pty Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. Buprenorphine Injectable Solution - Part A

    Indivior Pty Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  21. INDV-2000

    Indivior Pty Ltd

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  22. INDV-2000

    Indivior Pty Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  23. INDV-6200

    Indivior Pty Ltd

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  24. [14C]IDV184001AN

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

  25. 2.0mg Buprenorphine/0.5mg Naloxone

    Indivior Pty Ltd

    Hepatic Failure

    approved small molecule completed

    1 trial

  26. Buprenorphine (Subutex)

    Indivior Pty Ltd

    Opioid Dependency

    approved small molecule completed

    1 trial

  27. Buprenorphine + naloxone (Suboxone)

    Indivior Pty Ltd

    Opiate Dependence

    approved small molecule completed

    1 trial

  28. Buprenorphine Extended-Release Injection

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  29. INDV-6000-406

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule active

    1 trial

  30. P04843

    Indivior Pty Ltd

    Opiate Dependence

    approved small molecule completed

    1 trial

  31. PERSERIS

    Indivior Pty Ltd

    Schizophrenia

    approved small molecule completed

    1 trial

  32. Sublocade

    Indivior Pty Ltd

    Opioid Use Disorder, Severe

    approved small molecule completed

    1 trial

  33. Suboxone Sublingual Film

    Indivior Pty Ltd

    Opioid Dependence

    approved small molecule completed

    1 trial

  34. TM buprenorphine

    Indivior Pty Ltd

    Opioid-use Disorder

    approved small molecule completed

    1 trial

  35. Transmucosal Buprenorphine

    Indivior Pty Ltd

    Moderate to Severe Opioid-use Disorder

    approved small molecule completed

    1 trial

  36. buprenorphine

    Indivior Pty Ltd

    Hepatitis C, Chronic

    approved small molecule terminated

    1 trial

  37. buprenorphine

    Indivior Pty Ltd

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  38. buprenorphine and low-dose naloxone

    Indivior Pty Ltd

    Pain

    small molecule completed

    1 trial

  39. morphine sulfate

    Indivior Pty Ltd

    Analgesic Response

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Indivior Pty have?

39 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.